Skip to content
Unrated Drug recall · FDA · Published September 19, 2018

Upsher Smith Bumetanide Tablets Recall: Failed Impurities Risk

Upsher Smith recalls 2mg Bumetanide tablets due to failed impurities causing potential safety issues. Affected lots expire 3/31/2020 or 5/31/2020. Check your NDC number for recall.

🇺🇸 FDA recall #D-0281-2019DrugUpsher Smith ›
Take action

Contact the company

Recalling firmUpsher Smith Laboratories, Inc.6701 Evenstad Dr N · Maple Grove, MN 55369-6026
✎ GovInfoNow plain-language explainer

Upsher Smith is recalling 2mg Bumetanide tablets that failed impurity tests. This could pose safety risks if the tablets degrade, though the exact danger isn't specified in the recall notice. Read more at govinfonow.com/recall/39561-upsher-smith-bumetanide-tablets-recall-failed-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39561-upsher-smith-bumetanide-tablets-recall-failed-impurities-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-0281-2019

Cite this page

“Upsher Smith Bumetanide Tablets Recall: Failed Impurities Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39561-upsher-smith-bumetanide-tablets-recall-failed-impurities-risk. Based on FDA recall #D-0281-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0281-2019%22&limit=1).

The FDA announced on September 19, 2018, that Upsher Smith Laboratories, Inc. voluntarily recalled Bumetanide Tablets, USP, 2 mg, due to failed impurity specifications. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Upsher Smith
  • Product: Bumetanide Tablets, USP, 2 mg, 100-count bottle
  • NDC: 0832-0542-11
  • Lot codes: 372461, 372952, 372954, 372955, 373624, 374539 (Exp 3/31/2020); 375719, 375721, 376684 (Exp 5/31/2020)
  • Manufacturer: Upser-Smith Laboratories, LLC, Maple Grove, MN
  • Units affected: 29,080 bottles

The hazard

The product is out of specification for an unspecified degradation product. The FDA stated the hazard involves failed impurities and degradation specifications.

Context

GovInfoNow's records show Upsher Smith Laboratories, Inc. has four other recalls on record since November 20, 2012. Other recent recalls of similar products include Sagent Busulfan Injection Recall (May 4, 2026), Macleods Olanzapine Tablets 5mg Recall (August 27, 2026), and Hikma Ramipril Capsules 10mg Recall (August 24, 2026).

How to tell if you have this one

Check for the NDC number 0832-0542-11 on the bottle. Look for lot numbers 372461, 372952, 372954, 372955, 373624, 374539, 375719, 375721, or 376684. The expiration dates are 3/31/2020 or 5/31/2020.

  • Brand
    Upsher Smith
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide USA, Puerto Rico and Guam
  • NDC
    0832-0540-11, 0832-0541-11, 0832-0541-10, 0832-0542-11, 0832-0542-10
Recall numberProduct, codes & lotsQuantity
D-0280-2019Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11; Lot#: 375716, Exp 4/30/2020; 372957, 372958, 372959, Exp 3/31/2020; 374541, 375717, 376688, Exp 5/31/202044,764 bottles
D-0281-2019Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11; Lot#: 372461, 372952, 372954, 372955, 373624, 374539, Exp 3/31/2020; 375719, 375721, 376684, Exp 5/31/202029,080 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product

    Look for the NDC number 0832-0542-11 and the listed lot numbers on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide USA, Puerto Rico and Guam” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Sep 19, 201812. Published in FDA’s Enforcement Report: Oct 31, 201823. FDA classified it Class II: Nov 21, 201834. FDA terminated the recall: Sep 30, 2020420182020
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0281-2019 (September 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0281-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA